Participants 180 241 5
HIV-infected patients initiating antiretroviral therapy (ART)
Participants 384 572 6
106 ART-naive HIV-infected subjects who were randomized to receive efavirenz (EFV) + zidovudine/lamivudine (n = 32) or lopinavir/ritonavir (LPV/r) + zidovudine/lamivudine induction (n = 74
